Detalles de la búsqueda
1.
Correction: ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type.
PLoS Pathog
; 16(4): e1008531, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32343743
2.
Engagement of monocytes, NK cells, and CD4+ Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIVmac251 vaginal acquisition.
PLoS Pathog
; 16(3): e1008377, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32163525
3.
ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type.
PLoS Pathog
; 15(12): e1008121, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31794588
4.
Restricted valency (NPNA)n repeats and junctional epitope-based circumsporozoite protein vaccines against Plasmodium falciparum.
NPJ Vaccines
; 7(1): 13, 2022 Jan 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-35087099
5.
First-in-human assessment of safety and immunogenicity of low and high doses of Plasmodium falciparum malaria protein 013 (FMP013) administered intramuscularly with ALFQ adjuvant in healthy malaria-naïve adults.
Vaccine
; 40(40): 5781-5790, 2022 09 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36055874
6.
Therapeutic cardiac arrest as an adjunct to resuscitative endovascular balloon occlusion of the aorta: Bridging the gap from fatal hemorrhage to definitive surgical control in swine.
J Trauma Acute Care Surg
; 90(2): 369-375, 2021 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33502148
7.
Myeloid Cell Crosstalk Regulates the Efficacy of the DNA/ALVAC/gp120 HIV Vaccine Candidate.
Front Immunol
; 10: 1072, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31139193
8.
HIV vaccine candidate activation of hypoxia and the inflammasome in CD14+ monocytes is associated with a decreased risk of SIVmac251 acquisition.
Nat Med
; 24(6): 847-856, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29785023
Resultados
1 -
8
de 8
1
Próxima >
>>